Analyst Reco. MBX Biosciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-14 pm EDT			5-day change	1st Jan Change
32.81 ^USD	0.00%		+8.68%	+4.03%

Mar. 16	Mbx Biosciences Insider Bought Shares Worth $525,663, According to a Recent SEC Filing	MT
Mar. 12	MBX Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Jan. 28	Barclays Initiates Coverage on MBX Biosciences With Overweight Rating	MT
Jan. 07	UBS Initiates MBX Biosciences at Buy With $60 Price Target	MT
Dec. 04	Goldman Sachs Initiates Coverage on MBX Biosciences With Sell Rating, $18 Price Target	MT
Nov. 04	TD Cowen Initiates MBX Biosciences at Buy	MT
25-10-21	Mbx Biosciences Insider Bought Shares Worth $272,790, According to a Recent SEC Filing	MT
25-09-22	Oppenheimer Adjusts Price Target on MBX Biosciences to $80 From $38, Maintains Outperform Rating	MT
25-09-22	Ascendis Pharma's Yorvipath Faces No Threat From MBX Biosciences's Canvuparatide, Wedbush Says	MT
25-09-22	Guggenheim Adjusts Price Target on MBX Biosciences to $84 From $44, Maintains Buy Rating	MT
25-08-05	Mizuho Initiates MBX Biosciences at Outperform	MT
25-07-16	MBX Biosciences' Hypoparathyroidism Treatment a 'Key Catalyst,' Oppenheimer Says	MT
25-07-16	Oppenheimer Initiates MBX Biosciences at Outperform With $38 Price Target	MT
24-10-08	Stifel Initiates MBX Biosciences at Buy With $40 Price Target	MT
24-10-08	JPMorgan Initiates MBX Biosciences at Overweight With $30 Price Target	MT
24-10-08	Jefferies Initiates MBX Biosciences at Buy With $35 Price Target	MT
24-10-08	Guggenheim Initiates MBX Biosciences at Buy With $44 Price Target	MT